MicroTech Medical (Hangzhou) Co., Ltd. (02235) disclosed a share repurchase on 02 February 2026, involving 19,000 shares. The highest repurchase price reached HKD 7.64, the lowest price was HKD 7.31, and the transaction total amounted to HKD 139,946. All repurchased shares have been held as treasury shares.

Following this repurchase, MicroTech Medical reported a closing balance on 02 February 2026 of 165,769,042 issued shares (excluding treasury shares) and 3,406,800 treasury shares, maintaining a total of 169,175,842 shares. The repurchase was made under a mandate approved on 28 May 2025, authorizing up to 16,668,364 shares to be repurchased. To date, 854,600 shares have been repurchased under this mandate, representing approximately 0.5127% of the company’s issued shares (excluding treasury shares) as of the date of the resolution granting the mandate.